Recombinant Factor VIIa Is a Pan-hemostatic Agent?

Louis M. Aledort

doi:10.1055/s-0037-1613882

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2000; 83(05): 637-638
DOI: 10.1055/s-0037-1613882

Commentary

Schattauer GmbH

Recombinant Factor VIIa Is a Pan-hemostatic Agent?

Authors

Louis M. Aledort

¹From the Mount Sinai Medical Center, the Mount Sinai Hospital, New York, NY, USA

Abstract

Volltext

Referenzen

References
1 Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost 1999; 82: 531-4.
2 Monroe DM, Hoffman M, Oliver JA, Robert HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-7.
3 Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998; 80: 912-8.
4 Santagostino E, Gringeri A, Mannucci PM. Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention. Br J Haematol 1999; 104: 22-6.
5 Hedner U. Recombinant activated factor VII as a universal hemostatic agent. Blood Coag Fibrinol 1998; (Suppl. 01) 147-52.
6 d’Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Négrier C. Recombinant factor VIIa in Glanzmann’s thrombasthenia: A potential therapeutic place. Thromb Haemost 2000; 83: 644-7.
7 Turacek PL, Richter G, Muchitson EM, Pichler L, Schwarz HP, Morrissey J. Thrombogenicity of recombinant factor VIIa and recombinant soluble tissue factor in an in vivo rabbit model. Thromb Haemost 1997; Suppl. June: 222: 903.
8 Clinical experience with NovoSeven. Summary of efficacy and safety. August 1996.
9 European public assessment report on NovoSeven. 1996; 28: 10.
10 Peerlinck KK, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999; 82: 1775-6.